Molecular Insight Pharmaceuticals, Inc.

Scott Gottlieb's industry ties are likely to be a focus of his April 5 Senate confirmation hearing to be US FDA commissioner, but they seem unlikely derail his confirmation, and even the recusals he'l

Scott Gottlieb's industry ties are likely to be a focus of his April 5 Senate confirmation hearing to be US FDA commissioner, but they seem unlikely derail his confirmation, and even the recusals he'l

It used to be that the FDA's regulatory focus on therapies to treat rare diseases involved only a small segment of the agency's activities. But now, said Dr Gayatri Rao, director of the FDA's Office o

IN VITRO DIAGNOSTICS Mergers & Acquisitions Amarantus Bioscience Inc. Power3 Medical Products Inc. Amarantus BioScience Holdings Inc. (biologics and tests for CNS and cardiovascular diseases) is a